Trials / Completed
CompletedNCT04385810
Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The management of patients with SARS-CoV2 in respiratory distress can expose to corneal or retinal lesions induced by the stay in intensive care. Examination by ophthalmologists would make it possible to detect the most of the ophthalmologic problems known in intensive care and to provide an early, preventive or curative therapeutic response when possible, in order to avoid irreversible visual loss. The object of the research is to assess the presence and the importance of surface ophthalmologic lesions, the presence and the importance of retinal or optic nerve lesions, in order to improve the monitoring and primary prevention of this population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ophthalmologic exam | Direct exam and Slit lamp exam Shirmer test Retinophotography At inclusion, day 7, day 14 and discharge from hospital |
Timeline
- Start date
- 2020-04-27
- Primary completion
- 2020-07-29
- Completion
- 2020-07-29
- First posted
- 2020-05-13
- Last updated
- 2026-01-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04385810. Inclusion in this directory is not an endorsement.